Live Breaking News & Updates on Adaptive Sensory Technologies

Stay updated with breaking news from Adaptive sensory technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aflibercept Not for Prevention in Early Diabetic Retinopathy

Preventive treatment with anti-VEGF [such as aflibercept] for eyes with nonproliferative diabetic retinopathy generally is not a strategy that is warranted, says study investigator. ....

United States , Roche Genentech , American Medical Association , Sciences Inc , Boehringer Ingelheim , American Diabetes Association , Novo Nordisk , Medscape Medical , Year Trial , Diabetic Retinopathy Severity , Trialist Collaboration , Adaptive Sensory Technologies , Physical Sciences Inc , Boston Micromachines , Diabetic Retinopathy , Microvascular Complications Of Diabetes , Retinal Disease , Proliferative Diabetic Retinopathy , Diabetic Macular Edema , Macular Edema , Vegf Vascular Endothelial Growth Factor , Vascular Endothelial Growth Factor , Ascular Endothelial Growth Factor Vegf , Vision Care And Maintenance ,